Page 140 - PROGRAMME2018

TUESDAY, 3 JULY 2018
SELECTED ORAL COMMUNICATIONS
15:15 - 16:30 Room 113+114+115
Session 50: Genetic and epigenetic impact of assisted reproductive technologies
Chairman: A. Capalbo (Italy) Chairman: N. Costa-Borges (Spain)
15:15
15:30
O-179 Increased heteroplasmic load of coding mitochondrial DNA variants in tissues from ART children
J. Mertens1, F. Zambelli1, F. Belva2, A. Van Montfoort3, M. Bonduelle2, S. Seneca2, K. Sermon1, C. Spits1 1Vrije Universiteit Brussel, Reproduction and Genetics, Brussels, Belgium
2UZ Brussels, Center for Medical Genetics, Brussels, Belgium
3Maastricht University, Medical Centre, Maastricht, The Netherlands
O-180 Hypomethylation of imprinted genes in term placenta samples conceived by IVF/ICSI is associated with concomitant changes in post-translational histones modifications
C. Choux1, P. Petazzi2, M. Sanchez-Delgado2, J. Hernandez-Mora2, A. Monteagudo2, P. Sagot1, D. Monk2, P. Fauque3
1CHU Dijon Bourgogne, Service de Gynécologie-Obstétrique, 21000 Dijon, France
2Bellvitge Biomedical Research Institute, Imprinting and Cancer group- Cancer Epigenetic and Biology Program, 08908 L’Hospitalet de Llobregat- Barcelona, Spain
3CHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction, 21000 Dijon, France
O-181 Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
I. Derks-Smeets1, L. Schrijver2, C. De Die-Smulders1,3, V. Tjan-Heijnen3,4, R. Van Golde3,5, B. Caanen1, M. Rookus2, F. Van Leeuwen2, E. Gómez-Garcia1,3
1Maastricht University Medical Center, Clinical Genetics, Maastricht, The Netherlands 2Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, The Netherlands
3Maastricht University, GROW - School for Oncology and Developmental Biology, Maastricht, The Netherlands
4Maastricht University Medical Center, Internal Medicine - division of Medical Oncology, Maastricht, The Netherlands
5Maastricht University Medical Center, Obstetrics and Gynecology, Maastricht, The Netherlands
15:45
140